04 Nov 2021Ended

Novel Targets and Emerging Therapeutic Areas



09:00 AM - 06:00 PM
Not Verified

Official Links

Estimated Turnout

upto 100
Based on previous editions


Nov 2021
+1 more edition


Next edition likely in Nov 2022
Claim event to edit details

The proliferation of engineering approaches has accelerated the pace of exploring novel targets against cancer, autoimmune, inflammatory disease and .. Read more a range of other indications. The Novel Targets and Emerging Therapeutic Approaches program will highlight success with improved targeting and innovative solutions to address challenges that remain. Cancer immunotherapy has resulted in long-term durable benefit for some patients with otherwise terminal cancer. But why are we struggling to deliver a similar benefit to the majority of cancer patients? Presentation of clinical and biomarker data and scientific framework, challenges and engineered approaches will be discussed. This presentation aims to demonstrate the promise and challenges of T cell-engaging therapeutics, and to highlight the approach taken by Harpoon Therapeutics. With its extended serum half-life, small size, and very high potency of redirected cancer cell lysis, TriTACs promise to overcome limitations of other platforms.

  • Share your Experience
  • Organizer
Logo Follow Company

Cambridge Healthtech Institute

USA237 Total Events / 51 Upcoming Events

More Events From The Organizer